SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 115 filers reported holding SUTRO BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $531,794 | -39.7% | 153,255 | -19.2% | 0.00% | – |
Q2 2023 | $881,622 | +32.1% | 189,596 | +31.3% | 0.00% | – |
Q1 2023 | $667,211 | -63.8% | 144,418 | -36.6% | 0.00% | – |
Q4 2022 | $1,841,650 | +0.1% | 227,927 | -31.3% | 0.00% | – |
Q3 2022 | $1,840,000 | +6.4% | 331,573 | -0.2% | 0.00% | – |
Q2 2022 | $1,730,000 | -37.9% | 332,106 | -2.1% | 0.00% | – |
Q1 2022 | $2,788,000 | +194.7% | 339,186 | +434.2% | 0.00% | – |
Q4 2021 | $946,000 | +91.9% | 63,497 | +142.9% | 0.00% | – |
Q3 2021 | $493,000 | -86.3% | 26,143 | -86.5% | 0.00% | – |
Q2 2021 | $3,592,000 | -79.6% | 193,178 | -75.0% | 0.00% | -100.0% |
Q1 2021 | $17,596,000 | +515.9% | 773,106 | +487.4% | 0.00% | – |
Q4 2020 | $2,857,000 | +2673.8% | 131,620 | +1177.2% | 0.00% | – |
Q3 2020 | $103,000 | +123.9% | 10,305 | +74.8% | 0.00% | – |
Q2 2020 | $46,000 | +411.1% | 5,895 | +601.0% | 0.00% | – |
Q1 2020 | $9,000 | -95.4% | 841 | -95.2% | 0.00% | – |
Q4 2019 | $194,000 | -11.4% | 17,602 | -26.8% | 0.00% | – |
Q3 2019 | $219,000 | +2333.3% | 24,042 | +2824.8% | 0.00% | – |
Q2 2019 | $9,000 | -18.2% | 822 | -16.0% | 0.00% | – |
Q1 2019 | $11,000 | -87.5% | 978 | -90.0% | 0.00% | – |
Q4 2018 | $88,000 | – | 9,797 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |